Skip to main content
Signal8

Dalal Anupam

SEC insider (Form 3/4/5 filer). CIK 0001602474. Director at Whitehawk Therapeutics, Inc. (WHWK). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in MORRISTOWN, NJ.

Companies Dalal Anupam has filed insider reports for

  • Whitehawk Therapeutics, Inc. (WHWK): Director
Dalal Anupam profile photo

Dalal Anupam

CIK: 0001602474

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Whitehawk Therapeutics, Inc. logo
WHWK

Whitehawk Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2026
    Award

    Stock Option (right to buy)

    Direct
    38K shares-
  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    May 14, 2026
    Award
    Indirect
    1.3M shares at avg. $3.92$5.0M
  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2025
    Award

    Stock Option (right to buy)

    Direct
    40K shares-
  • Aadi Bioscience, Inc. logo
    AADI

    Aadi Bioscience, Inc.

    Mar 4, 2025
    Award
    Indirect
    1.6M shares at avg. $2.40$3.7M

1-4 of 4